Erasca, Inc. (ERAS) Free Cash Flow
Erasca, Inc. (ERAS) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2021-12-31 | -$98.48M |
| 2022-12-31 | -$119.81M |
| 2023-12-31 | -$122.99M |
| 2024-12-31 | -$109.48M |
| 2025-12-31 | -$95.58M |
How ERAS compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| QDEL | QuidelOrtho Corp Com | -$83.00M |
| ABEO | Abeona Therapeutics Inc. | -$84.30M |
| IMUX | Immunic Inc. | -$85.97M |
| INO | Inovio Pharmaceuticals Inc. | -$88.92M |
| AXSM | Axsome Therapeutics Inc. | -$93.89M |
These are five companies in the same sector as ERAS with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Erasca, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("ERAS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ERAS | $17.63 | +3.22% | 2.45M |
| 3 | ||||
| 4 | ||||
| 5 |